| Unknown | VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia Leukemia | Phase 2 | 2006-05-01 |
| Completed | VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | Phase 2 | 2005-11-01 |
| Completed | VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Canc Lung Cancer | Phase 2 | 2005-09-01 |
| Completed | VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Leukemia, Lymphoma | Phase 1 / Phase 2 | 2005-07-01 |
| Completed | Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia Leukemia | Phase 3 | 2005-03-01 |
| Completed | Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias Leukemia | Phase 1 | 2004-09-01 |
| Completed | VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies Leukemia, Myelodysplastic Syndromes | Phase 1 | 2003-06-01 |
| Completed | 3-AP and Cytarabine in Treating Patients With Hematologic Cancer Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | Phase 1 | 2003-03-01 |
| Completed | 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2003-01-01 |
| Completed | 3-AP and Gemcitabine in Treating Patients With Unresectable or Metastatic Pancreatic Cancer Pancreatic Cancer | Phase 2 | 2003-01-01 |
| Completed | 3-AP in Treating Patients With Advanced Prostate Cancer Prostate Cancer | Phase 2 | 2002-12-01 |
| Completed | VNP40101M in Treating Patients With Advanced or Metastatic Cancer Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2002-10-01 |
| Completed | VNP40101M in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndrome Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms | Phase 1 | 2002-04-01 |
| Completed | Combination Chemotherapy in Treating Patients With Advanced Cancer Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2001-03-01 |
| Completed | VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas Lymphoma, Small Intestine Cancer, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2001-03-01 |
| Completed | 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2000-12-01 |
| Completed | 3-AP in Treating Patients With Advanced Cancer Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2000-05-01 |
| Completed | VNP20009 in Treating Patients With Advanced Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2000-05-01 |
| Completed | VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous The Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1999-08-01 |
| Completed | 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 1998-05-01 |